Navigation Links
GenVec Reports Fourth Quarter And 2012 Year-End Financial Results
Date:3/22/2013

2013 GuidanceGenVec's Senior Vice President and Chief Financial Officer, Douglas J. Swirsky , commented, "For 2013, we anticipate our cash burn will be between $8.0 million and $9.0 million."

Conference Call InformationGenVec will hold a conference call today at 10:00 a.m. EDT to discuss the Company's financial results and 2013 business outlook.  To listen to the live conference call, please dial 877-558-0567 (U.S. or Canada) or 706-643-4980 (international) and use the following Conference ID: 17801867.  An audio replay of the conference call will be available starting at 1:00 p.m. EDT on March 22, 2013 through March 29, 2013.  To listen to the audio replay, dial 855-859-2056 or 404-537-3406 (international) and use access code 17801867.

A live webcast of the conference call will be available on the Company's website and will be archived for 30 days.  To access the webcast or the replay, go to www.genvec.com, and click on "Investors and Media".

About GenVecGenVec is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec's development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, malaria, and human immunodeficiency virus (HIV). In the area of animal health we are developing vaccines against foot-and-mouth disease (FMD). Addit
'/>"/>

SOURCE GenVec, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
2. GenVec Appoints Cynthia Collins as President and CEO
3. GenVec Reports Inducement Award
4. GenVec Announces Conditional Approval of FMD Vaccine for Cattle
5. GenVec to Release Second Quarter 2012 Financial Results and Conduct a Conference Call on August 9, 2012
6. GenVec Reports Second Quarter 2012 Financial Results
7. GenVec Reports Third Quarter 2012 Financial Results
8. GenVec to Present at 25th Annual ROTH Conference
9. GenVec To Release Fourth Quarter And Year-end 2012 Financial Results And Conduct A Conference Call On March 22, 2013
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 BreedIT Corp (OTC: ... worldwide distributor of highly sophisticated agro-breeding solutions for plant ... 2014, the Company,s board of directors appointed chemistry and ... its new member of the board. From ...
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... the risk of cancer returning,after surgery for ... April 12, 2007 /PRNewswire/ -- Investigators,will begin ... placebo in a major North American clinical ... Kit-positive,gastrointestinal stromal tumors treated with Gleevec following,surgery ...
... and NUTLEY, N.J., April 12, 2007,/PRNewswire-FirstCall/ -- ... trial program ever undertaken in the renal,anemia ... the,investigational anemia therapy MIRCERA(TM) for the treatment ... (CKD) in,patients on dialysis and not on ...
Cached Medicine Technology:Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 2Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 3Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 4Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 5Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 6Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study 7Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 2Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 3Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 4
(Date:4/17/2014)... identified the first genetic variant specifically associated with ... for around 10-15 per cent of all breast ... the breast cancer sub-type, called invasive lobular carcinoma, ... of this particular kind of breast cancer, which ... published today (Thursday) in the journal PloS ...
(Date:4/17/2014)... PLOS Pathogens , children who live in regions ... an immune response to infection with malaria parasites that ... fever and illness and partially control the growth of ... researchers develop future interventions that prevent or mitigate the ... approximately 200 million cases of malaria occur worldwide, resulting ...
(Date:4/17/2014)... 2014) Two recent papers by a University ... may help scientists develop treatments or vaccines for ... encephalitis and other disease-causing flaviviruses. , Jeffrey S. ... genetics at the School of Medicine and an ... Institute, and colleagues recently published articles in the ...
(Date:4/17/2014)... team has created a new technology for modifying ... travel the body and selectively target cancer and ... devices that monitor and modify human physiology is ... no existing technology enabled bioengineers to build such ... respond in a customized fashion. , "The project ...
(Date:4/17/2014)... that as many as 10 million older Americans suffer ... and isolation. , However, new research a project ... Americans for six years found that Internet use ... by more than 30 percent. , "That,s a very ... professor of telecommunication, information studies and media who led ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2Health News:Internet use can help ward off depression among elderly 2
... UNTIL WEDNESDAY - 29. APRIL 2009 AT 13.00 CET ... allowing doctors to detect hidden diseases and make ever ... the International Atomic Energy Agency (IAEA) say that overuse ... increased radiation levels. The IAEA, in collaboration with ...
... Record Quarterly Revenues: $33.7 million vs. $25.2 million - Increase of 34%Record ... Margins Improve to 11.9% , OWINGS MILLS, Md., April 29 Medifast, ... for the period ended March 31, 2009. First Quarter highlights included: ... First quarter revenues increased 34% compared to 2008 ...
... normally transmitted through the respiratory tract and spread when people come in ... ... April 29, 2009 -- When it comes to the recent swine flu ... Disease control and Prevention (CDC) in Atlanta, agree that the first order ...
... M.D. Rajesh Khanna, founder of the Khanna institute of LASIK ... most prominent LASIK, PRELEX and his expanding practice. , ... ... Khanna, founder of the Khanna Institute of LASIK, was featured in ...
... should ensure they are adequately covered." , ... Cardiff (PRWEB) April 29, ... 62%* amid fears over the spread of swine flu. As one country ... that they have adequate cover for any planned trips. , ...
... the Air Report Publishes Local Air Quality Grades Online -WASHINGTON, ... State of the Air report released today ... people -- live in areas where air pollution levels endanger ... substantial progress against air pollution in many areas of the ...
Cached Medicine News:Health News:IAEA calls for enhanced radiation protection of patients 2Health News:IAEA calls for enhanced radiation protection of patients 3Health News:IAEA calls for enhanced radiation protection of patients 4Health News:IAEA calls for enhanced radiation protection of patients 5Health News:Medifast Reports Record First Quarter 2009 Financial Results 2Health News:Medifast Reports Record First Quarter 2009 Financial Results 3Health News:Medifast Reports Record First Quarter 2009 Financial Results 4Health News:Medifast Reports Record First Quarter 2009 Financial Results 5Health News:Medifast Reports Record First Quarter 2009 Financial Results 6Health News:Medifast Reports Record First Quarter 2009 Financial Results 7Health News:Medifast Reports Record First Quarter 2009 Financial Results 8Health News:Medifast Reports Record First Quarter 2009 Financial Results 9Health News:Swine Flu Prevention: Information & Products from Allegro Medical 2Health News:Swine Flu Prevention: Information & Products from Allegro Medical 3Health News:Dr.Khanna Featured in Highly Respected Trade Journal 2Health News:Dr.Khanna Featured in Highly Respected Trade Journal 3Health News:Swine Flu Pandemic Sparks Travel Insurance Panic Buying, Says Confused.com 2Health News:Swine Flu Pandemic Sparks Travel Insurance Panic Buying, Says Confused.com 3Health News:New American Lung Association Report Finds 60 Percent of Americans Live in Areas Where Air is Dirty Enough to Endanger Lives 2Health News:New American Lung Association Report Finds 60 Percent of Americans Live in Areas Where Air is Dirty Enough to Endanger Lives 3Health News:New American Lung Association Report Finds 60 Percent of Americans Live in Areas Where Air is Dirty Enough to Endanger Lives 4Health News:New American Lung Association Report Finds 60 Percent of Americans Live in Areas Where Air is Dirty Enough to Endanger Lives 5Health News:New American Lung Association Report Finds 60 Percent of Americans Live in Areas Where Air is Dirty Enough to Endanger Lives 6Health News:New American Lung Association Report Finds 60 Percent of Americans Live in Areas Where Air is Dirty Enough to Endanger Lives 7
Quantitative Plasma-based Factor XIII Incorporation Assay Kit...
Assay for Determination of Initial Thrombin Formation...
Thrombin Activatable Fibrinolysis Inhibitor Assay Kit...
Pefakit PiCT LMWH Calibrators...
Medicine Products: